Lates News

According to documents from the Hong Kong Stock Exchange on May 12th, Mirxes Holding Company Limited appointed China International Capital Corporation Limited and China Industrial Securities International Capital Limited as its joint sponsors in its listing hearing on the HKEX. Mirxes, established in 2014, is a Singapore-based microRNA (miRNA) technology company. Its core product, GASTROClearTM, is a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening.